Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00257
|
|||||
Drug Name |
Biotin
|
|||||
Synonyms |
Biodermatin; Bioepiderm; Bios II; Biotin Forte; Factor S; Lutavit H2; Meribin; Rovimix H2
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Biotin ingestion [ICD11:5B5G] | Phase 4 | [1] | |||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C10H16N2O3S
|
|||||
Canonical SMILES |
C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2
|
|||||
InChI |
InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1
|
|||||
InChIKey |
YBJHBAHKTGYVGT-ZKWXMUAHSA-N
|
|||||
CAS Number |
CAS 58-85-5
|
|||||
Pharmaceutical Properties | Molecular Weight | 244.31 | Topological Polar Surface Area | 104 | ||
Heavy Atom Count | 16 | Rotatable Bond Count | 5 | |||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
0.3
|
|||||
PubChem CID | ||||||
PubChem SID |
10257672
,11108080
,11110441
,11466446
,11467566
,11486051
,14710116
,14798470
,14823272
,24276789
,24851733
,24871542
,24891512
,24891716
,24891778
,24891795
,26702910
,26703338
,26705359
,26711251
,26711284
,26711285
,26711287
,26716329
,26716331
,3139816
,3420
,6435803
,7847097
,7886365
,8022850
,8023123
,8028514
,8143739
,822205
,826027
,826557
,826666
,827176
,827375
,827480
,827863
,832719
,832724
,832725
,832726
,832727
,834418
,837148
,842100
|
|||||
ChEBI ID |
CHEBI:15956
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | MCT1 | Transporter Info | Monocarboxylate transporter 1 | Substrate | [2] | |
P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [3] | ||
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | P-GP | Transporter Info | Km =13 microM | Madin-Darby canine kidney (MDCK) cells-MDR1 | [3] | |
References | ||||||
1 | ClinicalTrials.gov (NCT03995277) Effect of Biotin on Routine Laboratory Values | |||||
2 | Biotin. Biofactors. 2009 Jan-Feb;35(1):36-46. | |||||
3 | Functional characterization of sodium-dependent multivitamin transporter in MDCK-MDR1 cells and its utilization as a target for drug delivery. Mol Pharm. 2006 May-Jun;3(3):329-39. |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.